Biotech startup Arnatar raises $50m Series A round to build China presence

Biotech startup Arnatar raises $50m Series A round to build China presence

Laboratory equipment. Photo: Pixabay

09 April, 2024

Edited by: Paramita Chatterjee

3E Bioventures antisense Arnatar Therapeutics biotech Eight Roads RNA

Printed by Unregistered user on Thu, 31 Jul 2025 05:57:33 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Danish biotech giant Genmab to buy Lilly Asia-backed ProfoundBio for $1.8b

Policy & Regulations

Chinese biotech firm WuXi AppTec denies it is a US national security threat

Read more from Greater China

China’s Wuxi Apptec to raise $980m via share placement

Prosus offloads $250m stake in Chinese food delivery giant Meituan: Report